Keebler Health has raised $16 Million in new Series A Funding
According to filings with the U.S. Securities and Exchange Commission, Keebler Health is raised $16 Million in new Series A funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Keebler Health
Keebler Health is an LLM-native health technology company building AI-powered infrastructure for value-based care. Its platform processes unstructured clinical documentation to surface missed HCC coding opportunities, enabling appropriate and accurate capturing of patient risk and delivering measurable revenue outcomes without disrupting existing clinical workflows. Keebler Health is headquartered in Durham, North Carolina.
To learn more, visit https://keebler.health/
Linkedin Page: https://www.linkedin.com/company/keeblerhealth/
Contact:
Isaac Park, Chief Executive Officer
https://www.linkedin.com/in/isaacpark/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
